⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TSHA News
Taysha Gene Therapies, Inc. Common Stock
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
TSHA
Form 8-K
sec.gov
TSHA
Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome
globenewswire.com
TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TSHA
Form 8-K
sec.gov
TSHA
Form 8-K
sec.gov
TSHA
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TSHA
Form 8-K
sec.gov
LXEO
VRTX
ALNY
MRK
TSHA
Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6
globenewswire.com
TSHA